Noninvasive Prenatal Diagnosis Strategy for a Clinical Trial

W. Holzgreve,H. Garrttsen,S. Tercanli,P. Miny,I. Nippert,D. Gänshirt
DOI: https://doi.org/10.1111/j.1749-6632.1994.tb55779.x
IF: 6.499
1994-09-01
Annals of the New York Academy of Sciences
Abstract:The motivation to develop a noninvasive technique for prenatal diagnosis stems from the fact that there will never be an invasive method, such as amniocentesis, chorionic villus sampling, or cordocentesis, without inherent procedure-related risks.' The history of previous attempts at developing noninvasive techniques has been summarized elsewhere.* Recently two American groups reported virtually identical techniques for the isolation of nucleated erythrocytes in maternal blood by multiparameter flow cytometry and subsequent fluorescence in situ hybridization (FISH).'s4 We developed an inexpensive technique for noninvasive prenatal detection of aneuploidies using a combination of triple-density gradient and magnetic sorting (MACS) of transferrin receptor antibody-labeled cells followed by FISH, and we have already reported the in utero detection of 16 cases with trisomies 21 and 18.5
What problem does this paper attempt to address?